Citigroup Downgrades Sunlight Finl Hldgs to Sell, Lowers Price Target to $2
Citigroup analyst Arren Cyganovich downgrades Sunlight Finl Hldgs (NYSE:SUNL) from Buy to Sell and lowers the price target from $4 to $2.
Piper Sandler Downgrades Olaplex Hldgs to Neutral, Lowers Price Target to $12
Piper Sandler analyst Korinne Wolfmeyer downgrades Olaplex Hldgs (NASDAQ:OLPX) from Overweight to Neutral and lowers the price target from $19 to $12.
Maxim Group Downgrades Kintara Therapeutics to Hold
Maxim Group analyst Jason McCarthy downgrades Kintara Therapeutics (NASDAQ:KTRA) from Buy to Hold.
Craig-Hallum Downgrades MillerKnoll to Hold, Lowers Price Target to $20
Craig-Hallum analyst Alex Fuhrman downgrades MillerKnoll (NASDAQ:MLKN) from Buy to Hold and lowers the price target from $50 to $20.
Stifel Downgrades O2Micro Intl to Hold, Lowers Price Target to $3.5
Stifel analyst Tore Svanberg downgrades O2Micro Intl (NASDAQ:OIIM) from Buy to Hold and lowers the price target from $5.5 to $3.5.
UBS Downgrades HUYA to Neutral, Lowers Price Target to $2.9
UBS analyst Felix Liu downgrades HUYA (NYSE:HUYA) from Buy to Neutral and lowers the price target from $27 to $2.9.
B of A Securities Downgrades Apple to Neutral, Lowers Price Target to $160
B of A Securities analyst Wamsi Mohan downgrades Apple (NASDAQ:AAPL) from Buy to Neutral and lowers the price target from $185 to $160.
Stifel Downgrades Cognyte Software to Hold, Lowers Price Target to $6
Stifel analyst Brad Reback downgrades Cognyte Software (NASDAQ:CGNT) from Buy to Hold and lowers the price target from $8 to $6.
BTIG Downgrades Applied Genetic to Neutral
BTIG analyst Yun Zhong downgrades Applied Genetic (NASDAQ:AGTC) from Buy to Neutral.
Needham Downgrades BTRS Holdings to Hold
Needham analyst Mayank Tandon downgrades BTRS Holdings (NASDAQ:BTRS) from Buy to Hold.